EVIDENCE OF DNA DAMAGE IN SUBJECTS WITH SEVERE HYPOTHYROIDISM AND DYSLIPIDEMIA.
- Department of Zoology, SreeNarayana College, Cherthala- 688582, Kerala.
- Associate Professor, Department of Biochemistry, Govt. Medical College, Malapuram-676121, Kerala.
- Assistant Professor, Department of Zoology, SreeNarayana College, Cherthala- 688582, Kerala.
- Genetika, Centre for Advanced Genetic Studies, Pettah P O, Thiruvananthapuram - 695024, Kerala.
- Abstract
- Keywords
- References
- Cite This Article as
- Corresponding Author
Thyroid diseases are one of the commonly occurring endocrine disorders worldwide. About 42 million people in India suffer from varied thyroid disorders. Thyroid hormones significantly affect lipoprotein metabolism as well as some CVD risk factors, thus influencing the overall CVD risk. The goal of the present study was to evaluate the evidence of DNA damage in subjects with severe hypothyroidism and dyslipidemia. The present study consists of 50 study subjects suffering from hypothyroidism along with dyslipidemia and 20 healthy control subjects. The extent of DNA damage was quantified by Cytokinesis-Block Micronuclei (CBMN) assay. Detailed demographic, clinical and lifestyle characteristics were compared with subjects. The micronuclei frequency was significantly elevated in study subjects as compared with that of control subjects. Various risk factors such as demographic, biochemical, hormonal and lifestyle characters were showed increased micronuclei, which leads to CVD. Thyroid disorders should be recognized and treated. Cardiovascular risk factors can be reduced by optimal metabolic control and lifestyle modification.
- Agarwal, G., Sudhakar, M. K., Singh, M., Senthil, N., Rajendran, A. (2011). ?The prevalence of thyroid dysfunction among South Indian women with Metabolic Syndrome? . J. of clinical & diagnostic research; 5(2): 213-216.
- Asvold, B. O., Vatten, L. J., Nilsen, T. I., Bjoro T. (2007). ?The associationbetween TSH within the reference range and serum lipid concentrations in a population-based study?. The HUNT Study. Eur J Endocrino; 156: 181-6.
- Canaris, G. J., Manowitz, N. R., Mayor, G., Ridgway, E. C. (2000). ?The Colorado thyroid disease prevalence study?. Arch Intern Med; 160(4): 526-34.
- Duntas, L. H. (2002). ?Thyroid disease and lipids?. Thyroid; 12: 287-93.
- Fan, A. Z., Russell, M., Stranges, S., et al. (2008).?Association of lifetime alcohol drinking trajectories with cardiometabolic risk?. J ClinEndocrinolMetab ; 93: 154-61.
- Fenech, M. (2007). ?Cytokinesis-block micronucleus cytome assay?. Nat Protoc; 2:1084?1104.
- Humayun, A., Shah, A. S., Alam, S., Hussein, H. (2009). ?Relationship of body mass index and dyslipidemia in different age groups of male and female population of Peshawar?. JAMC;21: 141?144.
- Klein, I and Ojamaa, K (2001). ?Thyroid hormone and the cardiovascular system?. N Engl J Med;344: 501-509.
- Kontush, A., Gu?rin, M., Chapman, M. J. (2008).?Spotlight on HDL-raising therapies: Insights from the torcetrapib trials?. Nat ClinPractCardiovasc Med; 5:329?36.
- Malnick, S. D. H., Knobler, H. B. (2006). ?The Medical Complications of Obesity?. Q J Med; 99:565?79.
- Maratou, E., Hadjidakis, D., Kollias, A., Tsegka, K., Peppa, M., Alevizaki, M., et al. (2009).?Studies of insulin resistance in patients with clinical and subclinical hypothyroidism?. Eur J Endocrinol; 130: 28-35.
- Martinez-Triguero, M. L., Hernandez-Mijares, A., Nguyen, T. T., et al., (1998).?Effect of thyroid hormone replacement on lipoprotein(a), lipids, and apolipoproteins in subjects with hypothyroidism?. Mayo ClinProc; 73:837?841.
- O'Brien, T., Dineen, S. F., O'Brien, P. C., Palumbo, P. J. (1993).?Hyperlipidemia in patients with primary and secondary hypothyroidism?. May ClinProc; 68:860?866.
- Resh, U., Helsel, G., Tatzber, F., Sinzinger, H. (2002). ?Anti-oxidant status in thyroid dysfunction?. Clin. Chem. Lab. Med; 40: 1132-1134.
- Shah, S. N., Joshi, S. R. (2011).?Think thyroid: Special Issue on Indian Thyroid Guidelines?. Journal of Associations of Physicians of India; 59(1).
- Stone, N. J. (2007). ?Secondary causes of hyperlipidemia?. Med Clin North Am; 78: 117-41.l; 156: 181-6.
- Tanis, B. C., Westendorp, G. J., Smelt, H. M. (1996).?Effect of thyroid substitution on hypercholesterolemia in patients with subclinical hypothyroidism: a reanalysis of intervention studies?. ClinEndocrinol; 44:643?649.
- Tanner, (2005). ?The Scientific Definition of Obesity and its Danger?. Mercola Author. Total Health Program.
- Yen, P. M. (2001). ?Physiological and molecular basis of thyroid hormone action?. Physiol Rev; 81: 1097-1142.
[Athulya Rajendran, Muhammed Ashraf K, Vidya PS and Dinesh Roy D. (2018); EVIDENCE OF DNA DAMAGE IN SUBJECTS WITH SEVERE HYPOTHYROIDISM AND DYSLIPIDEMIA. Int. J. of Adv. Res. 6 (Jan). 1072-1076] (ISSN 2320-5407). www.journalijar.com
Genetika, Centre for Advanced Genetic Studies, Pettah P O, Thiruvananthapuram - 695024, Kerala